Lims（实验室信息管理系统，Laboratory Information ManagementSystem）；是对实验室产生的各种信息进行管理的软件系统。通过该系统可以切实提高实验室管理工作效率，大大减轻实验室人员工作负担，从而提升服务水平，充分发挥实验室...Lims（实验室信息管理系统，Laboratory Information ManagementSystem）；是对实验室产生的各种信息进行管理的软件系统。通过该系统可以切实提高实验室管理工作效率，大大减轻实验室人员工作负担，从而提升服务水平，充分发挥实验室各种资源的作用，通顺实验室及其相关工作的业务流程。该文介绍的就是一个基于portal技术上的Liras系统。展开更多
Four calcium channel blockers, i.e. nifedipine, verapamil, cinnarizine and tetrandrine are currently available and used widely in treating cardiovascular diseases. To confirm the effects, if any, of calcium channel bl...Four calcium channel blockers, i.e. nifedipine, verapamil, cinnarizine and tetrandrine are currently available and used widely in treating cardiovascular diseases. To confirm the effects, if any, of calcium channel blockers on cirrhotic patients with portal hypertension, a study was performed on esophageal variceal pressure and rebleeding rate of esophageal varices after 2 years by using calcium channel blocker in 321 patients from some 23 hospitals. The results demonstrated that the calcium channel blockers could significantly reduce the esophageal variceal pressure and the portal blood flow in cirrhotic patients with portal hypertension. The proportion of patients with no recurrent gastrointestinal bleeding after 2 years medication of tetrandrine was 87.9% in tetrandrine group, significantly higher than those in the other 4 groups (P<0.05). It is suggested that tetrandrine should be more effective for cirrhotic patients with portal hypertension in preventing recurrent variceal bleeding.展开更多
文摘Lims（实验室信息管理系统，Laboratory Information ManagementSystem）；是对实验室产生的各种信息进行管理的软件系统。通过该系统可以切实提高实验室管理工作效率，大大减轻实验室人员工作负担，从而提升服务水平，充分发挥实验室各种资源的作用，通顺实验室及其相关工作的业务流程。该文介绍的就是一个基于portal技术上的Liras系统。
文摘Four calcium channel blockers, i.e. nifedipine, verapamil, cinnarizine and tetrandrine are currently available and used widely in treating cardiovascular diseases. To confirm the effects, if any, of calcium channel blockers on cirrhotic patients with portal hypertension, a study was performed on esophageal variceal pressure and rebleeding rate of esophageal varices after 2 years by using calcium channel blocker in 321 patients from some 23 hospitals. The results demonstrated that the calcium channel blockers could significantly reduce the esophageal variceal pressure and the portal blood flow in cirrhotic patients with portal hypertension. The proportion of patients with no recurrent gastrointestinal bleeding after 2 years medication of tetrandrine was 87.9% in tetrandrine group, significantly higher than those in the other 4 groups (P<0.05). It is suggested that tetrandrine should be more effective for cirrhotic patients with portal hypertension in preventing recurrent variceal bleeding.
